Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

PLAINS GP HOLDINGS LP (PAGP)

  • SEC News
  • May 08, 2026, 12:49 UTC
  • 2
  • 1 comments

(25% Negative) PLAINS GP HOLDINGS LP (PAGP) Reports Q2 2026 Financial Results

Comment Full text

PAYSAFE LIMITED COMMON SHARES (PSFE)

  • SEC News
  • May 08, 2026, 12:49 UTC
  • 3
  • 0 comments

New Form SCHEDULE 13G - Paysafe Ltd <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001142031-26-000006 <b>Size:</b> 6 KB

Comment Full text

ASSURED GUARANTY LTD (AGO)

  • SEC News
  • May 08, 2026, 12:48 UTC
  • 3
  • 1 comments

(99% Neutral) ASSURED GUARANTY LTD (AGO) Announces Regulatory Update

Comment Full text

PLAINS ALL AMERICAN PIPELINE LP (PAA)

  • SEC News
  • May 08, 2026, 12:48 UTC
  • 3
  • 1 comments

(25% Negative) PLAINS ALL AMERICAN PIPELINE LP (PAA) Reports Q2 2026 Financial Results

Comment Full text

JPMORGAN CHASE & CO (JPM)

  • SEC News
  • May 08, 2026, 12:46 UTC
  • 3
  • 0 comments

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001213900-26-053672 <b>Size:</b> 301 KB

Comment Full text

RGC RESOURCES INC (RGCO)

  • SEC News
  • May 08, 2026, 12:46 UTC
  • 3
  • 1 comments

(99% Neutral) RGC RESOURCES INC (RGCO) Files Form 8-K

Comment Full text

CITIGROUP INC (C)

  • SEC News
  • May 08, 2026, 12:46 UTC
  • 3
  • 0 comments

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0000950103-26-006988 <b>Size:</b> 159 KB

Comment Full text

JPMORGAN CHASE & CO (JPM)

  • SEC News
  • May 08, 2026, 12:45 UTC
  • 3
  • 0 comments

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001213900-26-053669 <b>Size:</b> 48 KB

Comment Full text

CG ONCOLOGY, INC. (CGON)

  • SEC News
  • May 08, 2026, 12:45 UTC
  • 3
  • 1 comments

(30% Negative) CG ONCOLOGY, INC. (CGON) Reports Q2 2026 Financial Results

Comment Full text

ATOSSA THERAPEUTICS, INC. (ATOS)

  • SEC News
  • May 08, 2026, 12:45 UTC
  • 3
  • 1 comments

(30% Negative) ATOSSA THERAPEUTICS, INC. (ATOS) Reports Q2 2026 Financial Results

Comment Full text
  • Previous
  • 180
  • 181
  • 182
  • 183
  • 184
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158460)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin